Apollo
logo
  1. Home
  2. salt
  3. Idarucizumab

Idarucizumab

About Idarucizumab

Idarucizumab is a prescription injection used to quickly reverse the blood-thinning effects of a specific medicine called dabigatran. It is used in emergency situations, such as when a patient experiences life-threatening or uncontrolled bleeding, or when they need to undergo an unplanned, urgent surgery. This medicine is only given by a healthcare professional in a hospital setting.

Because Idarucizumab is an emergency treatment, it is not used on a regular schedule or taken at home. It is injected directly into a vein, so food intake does not affect how it works. Since this is a critical rescue treatment, there are no specific long-term diet or lifestyle changes that directly alter its immediate effects, but managing your underlying heart or clotting conditions afterward is highly important.

Most people tolerate this injection well, but some may experience mild side effects like headache, constipation, or skin redness at the injection site. However, you should tell your healthcare team immediately if you experience signs of a serious allergic reaction, such as trouble breathing, a rapid heart rate, or severe itching.

Before receiving Idarucizumab, your healthcare team will review your medical history, particularly if you have a rare genetic condition called hereditary fructose intolerance, as some formulations may contain sorbitol. Do not take this if you have had a severe, life-threatening allergic reaction to this medicine in the past, though in emergencies, your doctor will carefully weigh the risks and benefits.

This medicine has very few direct interactions with other drugs, but restarting your usual blood-thinning therapy after receiving it must be carefully timed with your doctor. If you are pregnant, breastfeeding, or an older adult, your healthcare provider will closely monitor you, though emergency reversal is typically prioritized to protect your life.

Uses of Idarucizumab

Idarucizumab used in the treatment of severe or uncontrolled bleeding that has been caused by taking dabigatran (a medicine used to prevent blood clots). The detailed use of Idarucizumab is as follows: • Reversal of Dabigatran: Idarucizumab is a specific reversal agent used to neutralize the anticoagulant effects of dabigatran in emergencies, such as life-threatening or uncontrolled bleeding, to restore normal coagulation and control bleeding.

Medicinal Benefits

Idarucizumab provides rapid reversal of dabigatran's blood-thinning effects during medical emergencies. Its benefits include:

  • Rapidly neutralizes the anticoagulant effect of dabigatran, allowing normal blood clotting to resume within minutes.
  • Helps control uncontrolled or life-threatening bleeding, reducing the risk of severe blood loss and related complications.
  • Enables emergency surgery or urgent medical procedures to be performed more safely by reversing the blood-thinning effect before the procedure.
  • Supports faster stabilization during critical situations, improving the chances of successful emergency treatment.
  • Helps reduce the risk of prolonged bleeding complications when administered promptly under medical supervision.

Directions for Use

  • Follow your doctor's instructions on the dosage and timing of this medication.
  • Idarucizumab will be administered by a healthcare professional.
  • Do not self-administer it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Idarucizumab

Common Side Effects (Usually mild):

  • Headache
  • Constipation
  • Nausea
  • Mild fever


Serious Side Effects (Call a doctor right away):

  • Signs of an allergic reaction (such as skin rash, severe itching, swelling of the face, lips, or tongue, or wheezing)
  • Trouble breathing or shortness of breath
  • New blood clots (which can happen because the blood thinner has been turned off, potentially causing chest pain, leg swelling, or sudden weakness)

Drug Warnings

  • Verify solution appearance: The medical professional will inspect the vial before use; the solution should be clear to slightly opalescent, and colorless to slightly yellow. Do not use if there is visible discoloration or floating particles.
  • Watch for blood clot symptoms: Reversing your blood thinner increases your risk of developing a blood clot. Alert your doctor immediately if you experience sudden leg swelling, chest pain, or trouble speaking.
  • Plan the Restart of Blood Thinners: This medicine only reverses dabigatran temporarily. Once bleeding is controlled and it is medically safe, dabigatran can often be restarted after about 24 hours, although the exact timing depends on your condition, surgery, and bleeding risk. Follow your doctor's instructions carefully to reduce the risk of stroke or new blood clots.
  • Inform all healthcare providers: Always tell any doctor, dentist, or surgeon that you have recently received Idarucizumab and what blood-thinning medicines you normally take.

Drug Interactions

  • Blood thinners and antiplatelet medicines: While Idarucizumab does not have direct drug interactions, restarting blood thinners (like heparin or oral anticoagulants) too soon or too late can affect your clotting and bleeding risks.

Drug-Drug Interactions Checker List:

  • ROZANOLIXIZUMAB
  • EFGARTIGIMOD ALFA
  • Safety Advice

    • Safety Warning

      Alcohol

      consult your doctor

      It is not known if alcohol affects Idarucizumab. Please consult your doctor.

    • Safety Warning

      Pregnancy

      caution

      Idarucizumab should be given to pregnant women only if clearly needed. Inform the doctor if you are pregnant or think you may be pregnant.

    • Safety Warning

      Breast Feeding

      caution

      Caution is advised while administering Idarucizumab to a nursing woman.

    • Safety Warning

      Driving

      not applicable

      This medicine is for hospital use only.

    • Safety Warning

      Liver

      consult your doctor

      If you have a history of liver disease, inform your doctor before receiving Idarucizumab.

    • Safety Warning

      Kidney

      consult your doctor

      If you have a history of kidney disease, inform your doctor before receiving Idarucizumab.

    • Safety Warning

      Children

      caution

      The safety and effectiveness of Idarucizumab in children have not been established.

    Habit Forming

    No

    Diet & Lifestyle Advise

    • Follow blood thinner instructions carefully: Once your doctor determines it is safe to restart your regular blood-thinning medicine, take it exactly as prescribed to prevent stroke or blood clots.
    • Prevent falls and injuries: Since you are on blood thinners, minor injuries can cause serious bleeding. Use a soft-bristled toothbrush, shave with an electric razor, and avoid contact sports.
    • Eat a balanced diet: Maintain a steady diet and discuss any significant dietary changes with your healthcare provider, especially if you are transitioning to other types of blood thinners.
    • Limit alcohol intake: Alcohol can increase your risk of stomach bleeding and increase your risk of falls. Discuss safe alcohol limits with your doctor.

    Patients Concern

    Disease/Condition Glossary

    Bleeding: Bleeding is the loss of blood inside or outside the body. It is the main risk associated with dabigatran treatment. Severe or uncontrolled bleeding requires immediate medical attention to prevent loss of blood. Anticoagulant reversal agents such as Idarucizumab are used to treat severe and uncontrolled bleeding.

    FAQs

    Idarucizumab is used to treat severe or uncontrolled bleeding that has been caused by taking dabigatran (a medicine used to prevent blood clots).

    Idarucizumab rapidly traps dabigatran in order to inactivate its effect.

    Idarucizumab may contain sorbitol, which can cause serious or life-threatening metabolic problems in people with hereditary fructose intolerance (a genetic disorder). Therefore, inform the doctor if you have hereditary fructose intolerance.

    Idarucizumab does not remove other medicines used to prevent the formation of blood clots. It will only remove dabigatran from your body.

    No, Idarucizumab is strictly for hospital use and must be injected by a qualified healthcare professional in an emergency or surgical setting. Talk to your doctor if you have concerns about bleeding risks.

    While generally well-tolerated, serious side effects can include severe allergic reactions or an increased risk of developing a new blood clot. Talk to your doctor immediately if you notice signs like sudden leg swelling or difficulty breathing.

    Your doctor will decide the safest time to restart anticoagulation based on your bleeding risk and overall condition. In many patients, dabigatran can be restarted approximately 24 hours after receiving Idarucizumab once adequate bleeding control has been achieved. Delaying anticoagulation longer than necessary may increase the risk of stroke or blood clots, so always follow your doctor's advice.

    This medicine is only given in emergency situations when the benefits of stopping life-threatening bleeding outweigh the potential risks. Talk to your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

    There are no major known drug-drug interactions, but it is crucial to tell your healthcare team about all the medications and supplements you take, especially other blood thinners. Talk to your doctor or pharmacist for personalized advice.

    Author Details

    Doctor image
    We provide you with authentic, trustworthy and relevant information.
    Apollo 247 Floating Button
    idarucizumab | View uses, side-effects, medicines | Apollo Pharmacy